CHE - Chemed Corporation

NYSE - NYSE Delayed Price. Currency in USD

542.70

+9.27

(+1.74%)

At close: 04:00PM EDT

542.70

0.00

(0.00%)

After hours:

04:16PM EDT

Stock chart is not supported by your current browser

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

Commodity Channel Index

Performance Outlook

Short Term
2W - 6W
Mid Term
6W - 9M
Long Term
9M+

Previous Close	533.43
Open	532.93
Bid	0.00 x 900
Ask	0.00 x 1000
Day's Range	532.93 - 543.79
52 Week Range	430.16 - 570.17
Volume	73,012
Avg. Volume	64,915

Market Cap	8.151B
Beta (5Y Monthly)	0.54
PE Ratio (TTM)	33.56
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	1.52 (0.28%)
Ex-Dividend Date	May 24, 2023
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

-11% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CHE

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

News

Zacks
Here's Why You Should Retain Chemed (CHE) Stock for Now
Investors continue to be optimistic about Chemed (CHE) on the strong performance of the VITAS Healthcare and Roto-Rooter segments.
Zacks
DVA vs. CHE: Which Stock Should Value Investors Buy Now?
DVA vs. CHE: Which Stock Is the Better Value Option?
Zacks
AmerisourceBergen (ABC) Beats on Q2 Earnings, Ups '23 EPS View
AmerisourceBergen's (ABC) fiscal second-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.
Zacks
Stryker (SYK) Q1 Earnings Beat Estimates, Volume Improves
Stryker's (SYK) first-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.
Simply Wall St.
Is Chemed Corporation's (NYSE:CHE) Recent Stock Performance Tethered To Its Strong Fundamentals?
Chemed (NYSE:CHE) has had a great run on the share market with its stock up by a significant 11% over the last three...
Zacks
DexCom (DXCM) Q1 Earnings Beat Estimates, Volumes Remain Strong
DexCom's (DXCM) first-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
Zacks
Baxter (BAX) Beats on Q1 Earnings, Ups '23 EPS View
Baxter's (BAX) first-quarter 2023 results reflect sustained demand for its medically essential products amid a stabilizing macroeconomic climate and healthcare marketplace.
Zacks
West Pharmaceutical (WST) Q1 Earnings Beat, Order Book Strong
West Pharmaceutical's (WST) first-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.
Zacks
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms Guidance
Strength in the VITAS and Roto-Rooter branches contributes to Chemed's (CHE) first-quarter top line.
Zacks
CONMED (CNMD) Beats on Q1 Earnings, Ups '23 EPS View
CONMED's (CNMD) adjusted first-quarter sales and earnings recover from the disruption in the fourth quarter due to implementation of a new warehouse management system.
Zacks
Chemed (CHE) Q1 Earnings Lag Estimates
Chemed (CHE) delivered earnings and revenue surprises of -2.03% and 2.56%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks
EHC vs. CHE: Which Stock Is the Better Value Option?
EHC vs. CHE: Which Stock Is the Better Value Option?
Zacks
Here's Why Investors Should Hold Ensign Group (ENSG) Stock Now
Ensign Group (ENSG) remains well-poised for growth on the back of a growing revenue base, continuous pursuit of acquisitions and commendable financial position.
Zacks
PNTG vs. CHE: Which Stock Should Value Investors Buy Now?
PNTG vs. CHE: Which Stock Is the Better Value Option?
Zacks
Zacks Industry Outlook Highlights Chemed, Addus HomeCare, RadNet and The Pennant Group
Chemed, Addus HomeCare, RadNet and The Pennant Group are part of the Zacks Industry Outlook article.
Zacks
4 Promising Stocks From a Challenging Outpatient Home Health Industry
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. CHE, ADUS, RDNT and PNTG are well poised to gain from the prospects.
Zacks
Chemed (CHE) Up on Roto-Rooter Sales Growth, Strong Admissions
Chemed (CHE) records increases in drain cleaning, plumbing, excavation and water restoration revenues within the Roto-Rooter branch commercial business.
Zacks
Is Bellicum Pharmaceuticals (BLCM) Stock Outpacing Its Medical Peers This Year?
Here is how Bellicum Pharmaceuticals (BLCM) and Chemed (CHE) have performed compared to their sector so far this year.
Zacks
PNTG or CHE: Which Is the Better Value Stock Right Now?
PNTG vs. CHE: Which Stock Is the Better Value Option?
Simply Wall St.
Chemed Full Year 2022 Earnings: EPS Misses Expectations
Chemed ( NYSE:CHE ) Full Year 2022 Results Key Financial Results Revenue: US$2.13b (flat on FY 2021). Net income...
Thomson Reuters StreetEvents
Q4 2022 Chemed Corp Earnings Call
Q4 2022 Chemed Corp Earnings Call
Zacks
PNTG vs. CHE: Which Stock Is the Better Value Option?
PNTG vs. CHE: Which Stock Is the Better Value Option?
Zacks
Chemed (CHE) Q4 Earnings Beat Estimates, Margins Contract
Chemed (CHE) reports impressive sales growth in the Roto-Rooter subsidiary in the fourth quarter of 2022.
Zacks
Chemed (CHE) Tops Q4 Earnings and Revenue Estimates
Chemed (CHE) delivered earnings and revenue surprises of 1.70% and 0.63%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Simply Wall St.
Investors in Chemed (NYSE:CHE) have made a respectable return of 100% over the past five years
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...